Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Drug utilisation
Healthcare resource utilisation

Data collection methods

Secondary data collection
Non-interventional study

Non-interventional study design

Cohort
Other

Non-interventional study design, other

Healthcare cost
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(B01) ANTITHROMBOTIC AGENTS
(C01D) VASODILATORS USED IN CARDIAC DISEASES
(C02) ANTIHYPERTENSIVES
(C10) LIPID MODIFYING AGENTS
Population studied

Short description of the study population

Patients who have had an introduction to statin therapy.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

5000
Study design details

Main study objective

The study describes the annualized costs of care use in patients who have had an introduction to statin therapy and compares these costs between three cohorts defined by the level of adherence to statin therapy.

Outcomes

To describe annualized costs of care use in patients who have had an introduction to statin therapy and to compare these costs between three cohorts defined by the level of adherence to statin therapy. To identify the study population, factors associated with annualized costs and poor adherence to statins and compare cardiovascular events between the three cohorts.

Data analysis plan

A / General description of the study populationB / Description of the level of adherence to statinsC / Description and comparison of annualized costs generated by patientsD / Identification of factors associated with annualized costsE / Identification of factors associated with poor adherence to statin therapyF / Comparison of cardiovascular events between the three cohorts defined according to their level of adherence to statins